[HTML][HTML] CB1 receptor signaling in the brain: extracting specificity from ubiquity

A Busquets-Garcia, J Bains, G Marsicano - Neuropsychopharmacology, 2018 - nature.com
Endocannabinoids (eCBs) are amongst the most ubiquitous signaling molecules in the
nervous system. Over the past few decades, observations based on a large volume of work …

Endocannabinoid system in neurodegenerative disorders

BS Basavarajappa, M Shivakumar… - Journal of …, 2017 - Wiley Online Library
Most neurodegenerative disorders (NDD s) are characterized by cognitive impairment and
other neurological defects. The definite cause of and pathways underlying the progression …

[HTML][HTML] Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity

JE LaVigne, R Hecksel, A Keresztes, JM Streicher - Scientific reports, 2021 - nature.com
Limited evidence has suggested that terpenes found in Cannabis sativa are analgesic, and
could produce an “entourage effect” whereby they modulate cannabinoids to result in …

An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors

P Morales, PH Reggio - Cannabis and cannabinoid research, 2017 - liebertpub.com
The endocannabinoid system (ECS) has been shown to be of great importance in the
regulation of numerous physiological and pathological processes. To date, two Class A G …

Neurobiology of cannabinoid receptor signaling

B Lutz - Dialogues in clinical neuroscience, 2020 - Taylor & Francis
The endocannabinoid system (ECS) is a highly versatile signaling system within the nervous
system. Despite its widespread localization, its functions within the context of distinct neural …

[HTML][HTML] The endocannabinoid system as a target in cancer diseases: are we there yet?

E Moreno, M Cavic, A Krivokuca, V Casadó… - Frontiers in …, 2019 - frontiersin.org
The endocannabinoid system (ECS) has been placed in the anti-cancer spotlight in the last
decade. The immense data load published on its dual role in both tumorigenesis and …

[HTML][HTML] Polypharmacological approaches for CNS diseases: focus on endocannabinoid degradation inhibition

A Papa, S Pasquini, C Contri, S Gemma, G Campiani… - Cells, 2022 - mdpi.com
Polypharmacology breaks up the classical paradigm of “one-drug, one target, one disease”
electing multitarget compounds as potential therapeutic tools suitable for the treatment of …

[HTML][HTML] Striatopallidal adenosine A2A receptor modulation of goal-directed behavior: Homeostatic control with cognitive flexibility

JF Chen, DS Choi, RA Cunha - Neuropharmacology, 2023 - Elsevier
Dysfunction of goal-directed behaviors under stressful or pathological conditions results in
impaired decision-making and loss of flexibility of thoughts and behaviors, which underlie …

[HTML][HTML] Control of glutamate release by complexes of adenosine and cannabinoid receptors

A Köfalvi, E Moreno, A Cordomí, NS Cai… - BMC biology, 2020 - Springer
Background It has been hypothesized that heteromers of adenosine A 2A receptors (A2AR)
and cannabinoid CB 1 receptors (CB1R) localized in glutamatergic nerve terminals mediate …

[HTML][HTML] GPCR heteromers: An overview of their classification, function and physiological relevance

NC Dale, EKM Johnstone, KDG Pfleger - Frontiers in Endocrinology, 2022 - frontiersin.org
G protein-coupled receptors (GPCRs) are capable of interacting to form higher order
structures such as homomers and heteromers. Heteromerisation in particular has …